The ice cream cone was invented at the St. Louis Worlds Fair by Ernest Hamwi in 1904. His waffle booth was next to an ice cream vendor who ran short of dishes. Hamwi rolled a waffle to hold ice cream and the cone was born.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7056935 | Rotamase enzyme activity inhibitors This invention relates to methods of using neurotrophic compounds having an affinity for FKBP-type immunophilins to stimulate or promote neuronal growth or regeneration and to prevent neuronal degeneration. ... | 06/06/2006 |
| 6992207 | Melphalan derivatives and their use as cancer chemotherapeutic drugs The invention refers to new alkylating di- and tripeptides based on a melphalan unit, and one or two additional amino acids or amino acid derivatives, which can be used in the treatment of carcinogenic diseases. Further, the invention refers to a pharmaceutical comp... | 01/31/2006 |
| 6989402 | Thyroid receptor ligands and method II New thyroid receptor ligands are provided which have general formula (I) in which: n is an integer from 0 to 4; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or dif... | 01/24/2006 |
| 6849648 | Phenylene alkyne matrix metalloproteinase inhibitors A compound of Formula I or a pharmaceutically acceptable salt thereof, or a tautomer thereof, wherein G1, G2, and B are as defined in the application, are selective inhibi... | 02/01/2005 |
| 6806365 | N-alkanoylphenylalamine derivatives Compounds of the formula: are disclosed which have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related t... | 10/19/2004 |
| 6803384 | Diaminopropionic acid derivatives A compound of formula Id and pharmaceutically acceptable salts and esters thereof, wherein the substituent designations are as provided in the specification. Compounds of the invention are useful for treating reperfusi... | 10/12/2004 |
| 6720306 | Tetrapartate prodrugs A compound of Formula I, providing tetrapartate prodrugs is provided wherein: L1 is a bifunctional linking moiety; D is a moiety that is a leaving group, or a residue of a compound to be delivere... | 04/13/2004 |
| 6709679 | Antineoplastic conjugates of transferin, albumin and polyethylene glycol Conjugates of transferrin, albumin and polyethylence glycol consisting of native or thiolated transferrin or albumin or of polyethylene glycol (MW between approximately 5,000 and 20,0000) with at least one HS—, HO— or H2N group and cytostatic compound... | 03/23/2004 |
| 6664291 | Malonamic acids and derivatives thereof as thyroid receptor ligands The present invention relates to novel thyroid receptor ligands and, more particularly, relates to malonamic acids and derivatives thereof of Formula I, which are useful in the treatment of obesity, overweight condition, hyperlipidemia, glaucoma, cardiac ... | 12/16/2003 |
| 6610710 | Phenylalanine derivatives Phenylalanine derivatives of the following formula and analogues thereof have an antagonistic activity to 댔댧 integrin and a selectivity toward 댔댡 integrin. They are used as therapeutic agents for various diseases to which ... | 08/26/2003 |
| 6579987 | Diaryl-enynes Provided, among other things, is a compound of Formula I: ##STR1## wherein: Ar1 and Ar2 are independently selected aryl groups, optionally substituted with up to five substituents independently selected from the group consisting of a... | 06/17/2003 |
| 6469210 | Process for the preparation of phenylalkanoic acid amides and intermediates therefor A process for producing a phenylalkanoic acid amide of the formula [3] ##STR1## by reacting a carboxylic acid of the formula [1] ##STR2## with a dehydrating agent to produce an oxazolinone compound of the formula [2] ##STR3## and then reacting the ox... | 10/22/2002 |
| 6426364 | Diaryl-enynes Provided, among other things, is a compound of Formula I: ##STR1## wherein: Ar1 and Ar2 are independently selected aryl groups, optionally substituted with up to five substituents independently selected from the group consisting of a... | 07/30/2002 |
| 6395784 | Benzamide ligands for the thyroid receptor New thyroid receptor ligands are provided which have the general formula ##STR1## in which: X is --O--, --S--, --CH2 --, --CO--, or --NH--; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R... | 05/28/2002 |
| 6344590 | Adamantanemethanol derivatives and production processes thereof An adamantanemethanol derivative of the invention is represented by the following formula (1), wherein Ra is a hydrogen atom or a hydrocarbon group; Rb is a hydrocarbon group having a carbon atom, to which carbon atom at least one hy... | 02/05/2002 |
| 6339170 | Method for producing optically active phenylpropionic acid derivative Optically active N-(S-2-acetylthiomethyl-1-oxo-3-phenylpropyl)-glycine benzyl ester useful as an enkephalin inhibitory agent or ACE inhibitory agent can be produced at low cost in an industrial manner, by a method comprising subjecting optically active 2-... | 01/15/2002 |
| 6331640 | Diaminopropionic acid derivatives A compound of formula 1a ##STR1## which is useful for treating reperfusion injury, and salts, prodrugs, and related compounds.... | 12/18/2001 |
| 6274762 | Preparation of tri-iodo benzene compounds The invention provides an improved process for the preparation of a compound containing a 2,4,6-triiodinated benzene ring, said process comprising reacting a 2,4,6-unsubstituted 5-amino-benzoic acid or derivative there of with an iodine halide iodinating ... | 08/14/2001 |
| 6242607 | Disubstituted glutarimide method for preparing same, and use thereof The invention relates to glutarimides of formula (I): ##STR1## in which Ar represents a phenyl non substituted or substituted one or more times with one of the substituents selected from a halogen atom, a hydroxyl, a (C1 -C4)alkoxy, ... | 06/05/2001 |
| 6235929 | Tripeptide -ketoamides A novel class of tripeptide -ketoamides useful for selectively inhibiting serine proteases, selectively inhibiting cysteine proteases, generally inhibiting all serine proteases, and generally inhibiting all cysteine proteases, having the formula M | 05/22/2001 |
| 6229011 | N-aroylphenylalanine derivative VCAM-1 inhibitors Compounds of the formula: ##STR1## are disclosed which have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 ... | 05/08/2001 |
| 6153591 | Dipeptide caspase inhibitors and the use thereof The present invention is directed to novel dipeptides represented by the general Formula I: ##STR1## where R1 -R2 and AA are defined herein. The present invention relates to the discovery that compounds having Formula I are pote... | 11/28/2000 |
| 6121491 | Process for the preparation of (+/-)3-(3,4-dichlorophenyl)-2-dimethylamino-2-methylpropan-1-OL or cericlamine (INN) Process for the preparation of cericlamine which consists: i) in arylating methacrylic acid with the diazonium chloride of 3,4-dichloroaniline, to obtain (+/-)2-chloro-3-(3,4-dichlorophenyl)-2-methylpropionic acid, ii) in aminating the acid with dimethyla... | 09/19/2000 |
| 6071510 | Modified amino acids and compositions comprising the same for delivering active agents The present invention provides modified amino acids for delivering active agents, and particularly biologically or chemically active agents. The preferred modified amino acids of the present invention include N-acylated or sulfonated amino acids. These mo... | 06/06/2000 |
| 6046235 | Sulfur-containing amino acid derivatives A sulfur-containing amino acid compound having a high inhibitory activity on LTA4 hydrolase which is represented by the following formula: ##STR1## wherein R1 represents H, alkyl, optionally substituted phenyl alkyl, alkanoyl or... | 04/04/2000 |
| 6034266 | Gem-difluoro derivative of phenylacetamide and phenylacetic acid and their pharmaceutical uses The present invention refers to novel gem-difluoro compounds of formula: ##STR1## wherein: R1 can be hydrogen, acyl or acyl substituted; R2 is hydrogen, lower alkyl, lower alkyl substituted, nitro, halogen, methylenedioxy, trifl... | 03/07/2000 |
| 6017956 | N,N-disubstituted amic acid derivatives The present invention relates to a compound of the formula (I): ##STR1## wherein Ar1, Ar2, Ar3 and Ar4 represent an aryl group or a heteroaromatic ring group; A represents a hydrocarbon group which may be s... | 01/25/2000 |
| 6018050 | Method of preparing optically active -amino acids and -amino acid derivatives The invention relates to a new process for the preparation of optically active amino acids and amino acid derivatives of the general formula (I), wherein *, X and R1 to R4 have the meaning given in the description. Starting from comm... | 01/25/2000 |
| 5981794 | γ-oxo-homophenylalanine derivatives and process for producing homophenylalanine derivatives by reducing the same The present invention provides an economically advantageous and efficient process for producing an optically active homophenylalanine derivative of the general formula (IV), and an intermediate therefor and a process for producing it. The present inventio... | 11/09/1999 |
| 5973006 | Fluoro-substituted benzoylpropionic acid derivatives A fluoro-substituted benzoylpropionic acid compound of formula (I) either as a single optical isomer or as a mixture of optical isomers ##STR1## wherein R is hydroxy, amino, hydroxylamine, --OR', --NHR', N(R')2 or --NHOR' in which R' is C | 10/26/1999 |
| 5919786 | N,N-disubstituted amic acid derivatives The present invention relates to a compound of the formula (I): ##STR1## wherein Ar1, Ar2, Ar3 and Ar4 represent an aryl group or a heteroaromatic ring group; A represents a hydrocarbon group which may be s... | 07/06/1999 |
| 5907043 | Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase The present invention relates to pyrrolidine derivatives, and more particularly to the compound (S)-1-(S)-2-(4-methoxybenzamido)-3-methylbutyryl!-N-(S)-2-methyl-1-(trif luoroacetyl)propyl!pyrrolidine-2-carboxamide, shown by formula I, and solvates... | 05/25/1999 |
| 5905127 | Polymerizable mesophases based on substituted unsaturated carboxylic acids Mesogens are provided based on substituted unsaturated carboxylic acids such as acrylic and methacrylic acid. Substitution of a variety of hydrophobic tails onto the carboxylic acid or acid derivative via the vinyl carbon proximal to the carbonyl of the c... | 05/18/1999 |
| 5871755 | Dehydroalanine derivatives for protecting the skin, the mucous membranes and/or the hair from oxidative stress, cosmetic or dermatological compositions containing them The present invention relates to the use of dehydroalanine derivatives of formula (I) ##STR1## with R1 : H or linear- or branched-chain C1 C4 alkyl, ##STR2## or linear- or branched-chain C1 -C20 | 02/16/1999 |
| 5863947 | Phenylglycine derivatives useful for treating disorders of the central nervous system A pharmaceutical compound of the formula: ##STR1## in which R1 is hydrogen, hydroxy or C1-6 alkoxy, R2 is hydrogen, carboxy, tetrazolyl, --SO2 H, --SO3 H, --OSO3 H, --CONHOH, or --P(OH... | 01/26/1999 |
| 5804581 | Inhibition of matrix metalloproteases by substituted phenalkyl compounds Matrix metalloprotease inhibiting compounds, pharmaceutical compositions thereof and a method of disease treatment using such compounds are presented. The compounds of the invention have the generalized formula: ##STR1## wherein T is a substituent an... | 09/08/1998 |
| 5783735 | Process for preparing polymeric amides useful as additives in fuels and lubricating oils A process for preparing polymeric amides is disclosed. The process comprises sequentially reacting a hydrocarbon polymer functionalized (e.g., via the Koch reaction) to contain acid, ester, thioacid and/or thioester groups with a heavy polyamine to form a... | 07/21/1998 |
| 5719306 | LTA4 hydrolase inhibitors The present invention provides compounds of the formula Ar1 --Q--Ar2 --Y--R--Z and pharmaceutically acceptable salts thereof wherein Ar1 and Ar2 are optionally substituted aryl moieties, Z is an optionally subst... | 02/17/1998 |
| 5703095 | Use of N-arylmethylene, ethylenediaminetriacetates, N-arymethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress N-arylmethylene ethylenediaminetriacetate, N-arylmethylene iminodiacetate or N,N'-diarylmethylene ethylenediaminediacetate type compounds and their use in combatting oxidative stress, and pharmaceutical and cosmetic compositions comprising said compounds.... | 12/30/1997 |
| 5643958 | Substituted amide derivatives The present invention relates to a compound of the formula (I): ##STR1## wherein Ar1, Ar2 and Ar3 represent an aryl group or a heteroaromatic ring group; A represents a hydrocarbon group which may be substituted; Q re... | 07/01/1997 |